US Corporate Distress Financial Stress SEC Filings — March 27, 2026

27-03-2026

AnaptysBio's Board of Directors approved the spin-off of First Tracks Biotherapeutics, Inc., with a distribution date of April 20, 2026 (record date April 6, 2026), providing Anaptys stockholders one share of First Tracks Bio (ticker: TRAX) common stock per Anaptys (ANAB) share held. First Tracks Bio will launch as a clinical-stage biotech with $180 million initial cash ($100 million from Anaptys, $80 million from private placement), a two-year cash runway, and a pipeline including ANB033 (Phase 1b), rosnilimab (Phase 2b completed), and ANB101 (Phase 1a). Daniel Faga will serve as CEO of both companies post-spin-off, with additional leadership including Paul Lizzul (CMO), Ben Stone (CBO), and incoming CFO Ajim Tamboli.

• ·Spin-off distribution expected April 20, 2026, pre-market; record date April 6, 2026.
• ·When-issued trading for TRAX begins on or about April 6, 2026; regular-way trading April 20, 2026.
• ·U.S. federal income tax purposes: distribution expected to be taxable for Anaptys.
• ·No action required by Anaptys stockholders; no payment or share surrender needed.
• ·Ajim Tamboli (>25 years experience) starts as CFO on April 20, 2026.
• ·Investor contact: Nick Montemarano, 858.732.0178, investors@anaptysbio.com

27-03-2026

Delek Logistics Partners, LP entered into a new Credit Agreement dated March 26, 2026, with Truist Bank as Administrative Agent, various lenders including Bank of America, N.A., Citizens Bank, N.A., The Huntington National Bank, Mizuho Bank, Ltd., MUFG Bank, Ltd., and Wells Fargo Bank, N.A. as Co-Syndication Agents, and Barclays Bank PLC, KeyBanc Capital Markets Inc., and Regions Bank as Co-Documentation Agents. The agreement refinances the prior Fourth Amended and Restated Credit Agreement dated October 13, 2022, with Fifth Third Bank as prior agent, and supports revolving loans, letters of credit, swing loans for working capital, investments, capital expenditures, restricted payments, and general corporate purposes. No specific facility size or terms changes indicate improvements or declines.

• ·SEC 8-K filing dated March 27, 2026, covering Items 1.01, 1.02, 2.03, 9.01
• ·Effective Date Refinancing of prior indebtedness under October 13, 2022 agreement
• ·Includes collateral, guaranties, financial covenants, and standard events of default

27-03-2026

Two Harbors Investment Corp. (TWO) announced a definitive merger agreement to be acquired by an affiliate of CrossCountry Mortgage (CCM) for $10.80 per share in cash, terminating its prior merger agreement with UWM Holdings Corporation dated December 17, 2025, and agreeing to pay a $25.4 million termination fee to UWM. The transaction, unanimously approved by TWO's board and recommended for stockholder approval, is expected to close in the second half of 2026, subject to customary conditions including regulatory approvals, with no financing condition. Holders of TWO's preferred stock will be redeemed at $25.00 per share plus accumulated dividends, while TWO plans to continue regular quarterly dividends prior to closing but no partial dividend in the closing quarter.

• ·TWO's prior stockholder meeting scheduled for April 7, 2026, to approve UWM merger has been canceled.
• ·Transaction not subject to financing condition; TWO common stock to be delisted from NYSE upon closing.
• ·Advisors: Houlihan Lokey (financial) and Jones Day (legal) for TWO; Citigroup (financial) and Simpson Thacher & Bartlett (legal) for CCM.

27-03-2026

KKR Enhanced US Direct Lending Fund-L Inc., as Collateral Manager, and KKR Enhanced US EVDL Funding LLC, as Borrower, entered into Amendment No. 2 to the Loan and Servicing Agreement dated March 23, 2026, amending the original April 1, 2024 agreement with Citibank, N.A. as Administrative Agent and The Bank of New York Mellon Trust Company, National Association as Collateral Agent. The amendment updates the conformed Loan and Servicing Agreement to provide a secured revolving credit facility of up to U.S.$1,250,000,000 for financing Eligible Collateral Assets. No Events of Default were reported, and all representations and warranties remain true and correct post-amendment.

• ·Amendment effective upon execution, delivery of good standing certificate, board resolutions, and legal opinion from Dechert LLP.
• ·Original Loan and Servicing Agreement dated April 1, 2024.
• ·Governed by New York law.

27-03-2026

Cyber Enviro-Tech, Inc. (CETI) entered into an Equity Purchase Agreement with Monroe Street Capital Partners, LP on March 20, 2026, providing the right to sell up to $30,000,000 of common stock over a 24-month Commitment Period, subject to conditions including put notices with minimum $25,000 and maximum $500,000 per put. As consideration, CETI issued 3,000,000 Initial Commitment Shares immediately and agreed to issue additional 3,000,000 Fulfillment Commitment Shares upon each of the first three $2,500,000 gross proceeds milestones. Concurrently, a Registration Rights Agreement requires filing a resale registration statement within 30 days and maintaining its effectiveness.

• ·Commitment Period: 24 months from March 20, 2026, or earlier termination events.
• ·Registration Statement filing deadline: within 30 calendar days after March 20, 2026.
• ·Registration effectiveness target: within 90 calendar days after filing.
• ·Common Stock trading symbol: CETI on OTCQB.
• ·Principal Executive Offices: 6991 E. Camelback Road, Suite D-300, Scottsdale, Arizona 85251.

27-03-2026

Cartesian Growth Corporation III (CGC), a SPAC, entered into an Amendment to its Business Combination Agreement dated December 17, 2025, with Merger Sub (Fenway MS, Inc.) and Factorial Inc., effective March 26, 2026. The amendments adjust the timing of CGC Shareholder Redemption to occur at least one day prior to Domestication, update definitions including Ancillary Documents, Company Convertible Notes, Required Transaction Proposals, and Nasdaq Proposals, add pre-Domestication actions, and reserve Sections 5.21 and 5.22. No financial terms or impacts are disclosed in the amendment.

• ·Original Business Combination Agreement dated December 17, 2025
• ·Amendment governed by New York law with exclusive jurisdiction in New York courts
• ·Includes updates to Preamble paragraphs regarding Shareholder Redemption and Registration Rights Agreement

27-03-2026

On March 25, 2026, Honda Canada Finance Inc. (HCFI), a subsidiary of American Honda Finance Corp., executed the Second Amendment to its C$2,000,000,000 ($1,455,498,144.20 USD) Third Amended and Restated Credit Agreement, extending the Tranche A commitment termination date from March 25, 2026, to March 25, 2027 (up to C$1,000,000,000 or $727,749,072.12 USD), and Tranche B from March 25, 2027, to March 25, 2029 (up to C$1,000,000,000 or $727,749,072.12 USD). The amendment also permits further extension of Tranche B commitments up to three years upon HCFI request and updates a reference date in Section 8.4 from March 31, 2024, to March 31, 2025. No declines or flat metrics reported; the changes enhance liquidity access.

• ·Exchange rate used for USD conversions: 1.3741 CAD per USD as of March 23, 2026.
• ·Amendment filed as Exhibit 10.1.

27-03-2026

On March 22, 2026, Totaligent, Inc. entered into an Extension Amendment to its Binding Letter of Intent dated February 22, 2026, with GloMed Solutions Limited Liability Company, extending the target dates for negotiating definitive agreements (including joint venture and IP assignment agreements) and closing the proposed transaction to April 22, 2026. The binding exclusivity period under the LOI is also extended through April 22, 2026. All other terms of the LOI, which outlines a joint venture formation and a call option for Totaligent to acquire GloMed's business, operations, IP, and assets, remain unchanged.

• ·Original LOI disclosed in 8-K filed February 23, 2026
• ·Extension Amendment filed as Exhibit 10.1

27-03-2026

On March 24, 2026, The Hain Celestial Group, Inc. received a notice from Nasdaq Listing Qualifications Staff indicating that its common stock (HAIN) failed to comply with the minimum bid price requirement under Nasdaq Listing Rule 5450(a)(1), as the bid price closed below $1.00 for 30 consecutive business days. The company has an initial 180-calendar-day compliance period until September 21, 2026, to regain compliance by sustaining a closing bid price of at least $1.00 for 10 consecutive business days, with no immediate impact on current trading. While the company intends to monitor the bid price and consider a reverse stock split at its 2026 annual meeting if needed, it acknowledges no assurance of regaining or maintaining compliance, potentially facing delisting.

• ·Common Stock, par value $0.01 per share, continues to trade on Nasdaq Global Select Market under symbol 'HAIN' with no immediate delisting effect.
• ·To qualify for second 180-day period, must meet market value of publicly held shares and other initial listing standards (except bid price).
• ·Company may appeal any delisting determination to a Nasdaq hearings panel, but success is not assured.

27-03-2026

PMGC Holdings Inc.'s wholly-owned subsidiary Northstrive Biosciences Inc. entered into the Third Amendment to its License Agreement with MOA Life Plus Co., Ltd. on March 24, 2026, amending Exhibit C to update development milestones and timelines for the human health field, including pre-clinical studies, IND submission, and Phases 1-3 trials leading to FDA marketing approval (specific timelines redacted). The amendment includes a provision allowing Northstrive to potentially skip the Phase 1 clinical trial for the licensed product BLS-M22 and proceed directly to Phase 2 under certain conditions, with the associated milestone payment combined. As consideration, PMGC must pay a one-time, non-creditable, non-refundable amendment fee (amount redacted) upon execution and within 30 days.

• ·Original License Agreement dated April 30, 2024; First Amendment in March 2025 expanding field to animal health; Second Amendment on May 12, 2025 clarifying animal health provisions.
• ·Assignment of original agreement from PMGC to Northstrive on February 28, 2025.

27-03-2026

Pluri Inc. entered into a Securities Purchase Agreement on March 25, 2026 (effective March 24, 2026) with Chutzpah Holdings LP, beneficially owned by director Alexandre Weinstein, for a private placement of 625,000 common shares and warrants to purchase 625,000 common shares at a combined price of $4.00 per unit, expected to yield gross proceeds of $2.5 million for working capital and general corporate purposes. The offering is set to close by end of April 2026, with warrants exercisable immediately at $4.25 per share for 18 months, subject to a 35% beneficial ownership limit. No declines or flat metrics reported in this financing announcement.

• ·Warrants exercisable at $4.25 per share until 18-month anniversary of closing.
• ·Securities exempt under Section 4(a)(2) of Securities Act and Rule 903 of Regulation S.
• ·Closing subject to customary conditions, expected end of April 2026.

27-03-2026

Streamex Corp. refuted inaccurate third-party claims from March 23, 2026, attributing to S&P Capital IQ on MarketScreener, which alleged 89,833,535 shares under lock-up agreements expiring March 24, 2026; the Company clarified that only 42,887,599 shares were subject to customary 60-day lock-ups from the January 26, 2026 financing. Co-Founders Morgan Lekstrom and Henry McPhie voluntarily entered into new 1-year lock-up agreements on March 26, 2026, agreeing not to sell or transfer any common stock shares without Company consent, demonstrating strong shareholder alignment amid GLDY launch. No declines or flat metrics reported in this non-financial clarification.

• ·Prior lock-up agreements dated January 22, 2026, for 60 days tied to confidentially marketed public offering on January 26, 2026, with all issued shares freely tradable.
• ·No executive officers, directors, or others held warrants, options, preferred stock, or other securities under the referenced lock-ups.
• ·January 26, 2026 financing shares not subject to any lock-up restrictions.

27-03-2026

Alight, Inc. received a NYSE notice on March 24, 2026, for failing to meet the continued listing standard under Section 802.01C, as the average closing price of its Class A common stock was below $1.00 over the 30 trading-day period ending March 20, 2026. The notice has no immediate impact on business operations or SEC reporting, but the company has a six-month cure period to regain compliance, potentially via reverse stock split subject to stockholder approval. Alight issued a press release on March 27, 2026, affirming its intent to address the deficiency.

• ·Compliance cure period: six months from March 24, 2026.
• ·Regain compliance if closing price >= $1.00 and 30-day average >= $1.00 on last trading day of any month during cure period.
• ·Press release furnished as Exhibit 99.1.

27-03-2026

Trio Petroleum Corp entered into a Settlement Agreement with McDermott Will & Schulte LLP on March 24, 2026, to settle outstanding legal fees of $392,700.23 by issuing 446,149 restricted shares of its common stock (par value $0.0001 per share). The company committed to filing a resale registration statement within 20 calendar days after issuance and using commercially reasonable efforts to achieve effectiveness within 45 days, with both parties providing mutual releases of all related claims and liabilities.

• ·Shares issued in reliance on Section 4(a)(2) exemption under the Securities Act of 1933.
• ·Par value of common stock: $0.0001 per share.
• ·Mutual release covers all liabilities, claims, and costs related to the fees and prior acts/omissions.

27-03-2026

Norwegian Cruise Line Holdings Ltd. (NCLH) announced the appointment of five new independent directors effective March 31, 2026—Alex Cruz, Kevin A. Lansberry, Steve Pagliuca, Brian P. MacDonald, and Jonathan Z. Cohen—following a cooperation agreement with Elliott Investment Management L.P. to enhance board refreshment and shareholder value. Four directors—Stella David, David M. Abrams, Harry C. Curtis, and Mary E. Landry—will resign, resulting in a nine-member board with eight independents; John W. Chidsey is appointed Chairman and Alex Cruz as Lead Independent Director. The changes aim to improve execution amid strategic growth, with NCLH's fleet at 35 ships and nearly 75,000 Berths, planning 16 more ships adding over 43,000 Berths by 2037.

• ·Company slate for 2026 Annual General Meeting: Zillah Byng-Thorne, Linda P. Jojo, Alex Cruz.
• ·Elliott agreed to customary standstill and voting commitments in cooperation agreement.
• ·Advisors: Goldman Sachs & Co. LLC (financial), Paul Hastings LLP (legal), Joele Frank, Wilkinson Brimmer Katcher (strategic communications).

27-03-2026

Camden Property Trust entered into a letter agreement dated March 24, 2026, confirming Richard J. Campo's position as Executive Chairman of the Board of Trust Managers, effective immediately, with duties under the Board's control and direction. The agreement clarifies that determinations of 'Good Reason' under prior agreements will reference this position. It was executed by Joshua A. Lebar, Senior Vice President-General Counsel and Secretary, and accepted by Mr. Campo.

• ·Letter agreement references address: 2800 Post Oak Boulevard, Suite 2700, Houston, Texas 77046
• ·Filing includes Items 1.01 (Material Agreement), 5.02, 5.03, 9.01

27-03-2026

OFS Capital Corporation executed an amendment to its senior secured revolving credit facility with Banc of California, relaxing the minimum tangible net asset value covenant from $100.0 million to $75.0 million and reducing the minimum quarterly net investment income after fees covenant from $2.0 million to $1.0 million for quarters ending March 31, 2026, June 30, 2026, and September 30, 2026 (reverting to $2.0 million thereafter). However, the maximum commitment amount was decreased from $25.0 million to $15.0 million, potentially limiting liquidity. The amendment incurs customary fees and is detailed in Exhibit 10.1.

• ·Amendment dated March 27, 2026, filed as Exhibit 10.1
• ·Company address: 222 W. Adams Street, Suite 1850, Chicago, Illinois 60606
• ·Registrant details: Delaware incorporation, Commission File Number 814-00813, I.R.S. Employer Identification No. 46-1339639

27-03-2026

Iterum Therapeutics plc filed a petition in the Irish High Court to wind up the company, resulting in the appointment of Damien Murran and Jennifer McMahon as Joint Provisional Liquidators, with the hearing scheduled for April 13, 2026. The decision stems from limited cash resources, Nasdaq listing non-compliance, failed acquisition talks for sulopenem, and modest sales of ORLYNVAH amid high operating costs. Provisional liquidators may withdraw ORLYNVAH from the U.S. market and oversee wind-down of subsidiaries.

• ·Petition filed March 27, 2026; hearing on April 13, 2026.
• ·Stakeholder inquiries: Iterum.Liquidation@teneo.com.
• ·Provisional liquidators also appointed to Irish subsidiary.

27-03-2026

Harrow, Inc. entered into a purchase agreement dated March 24, 2026, to issue and sell $50,000,000 principal amount of 8.625% Senior Notes due 2030 (the 'Securities') to initial purchasers represented by BTIG, LLC, constituting additional notes under the existing Base Indenture dated September 12, 2025. These Securities supplement the previously issued $250,000,000 aggregate principal amount of the same notes and are guaranteed by the Guarantors on an unsecured senior basis. The notes are priced at 98.0% of principal amount plus accrued interest from March 15, 2026, with closing scheduled for March 27, 2026.

• ·Securities issued pursuant to Base Indenture dated September 12, 2025, supplemented by Supplemental Indenture on Closing Date
• ·Sold in reliance on exemption from Securities Act registration to qualified institutional buyers under Rule 144A
• ·Payment and delivery at 10:00 A.M. New York City time on March 27, 2026, or as agreed
• ·Global Note delivered to nominee of The Depository Trust Company (DTC)

27-03-2026

ZW Data Action Technologies Inc. (CNET) received a Nasdaq Deficiency Letter on March 26, 2026, stating non-compliance with Listing Rule 5550(a)(2) due to its common stock bid price closing below $1.00 for 30 consecutive business days. The Company has 180 calendar days until September 22, 2026, to regain compliance by achieving a $1.00 bid price for 10 consecutive business days, with trading continuing uninterrupted for now. However, failure to comply risks delisting, and while the Company intends to monitor and explore options like a reverse stock split, no assurance of success is provided.

• ·Nasdaq Listing Rule 5550(a)(2): Minimum Bid Price Requirement.
• ·Potential eligibility for second 180-day compliance period if other listing standards met, excluding bid price.
• ·Company address: 8/F, 29 Des Voeux Road Central, Central, Hong Kong Special Administrative Region.
• ·Trading symbol: CNET.

27-03-2026

Sotherly Hotels Inc. announced its board's approval for the voluntary delisting of its 8.0% Series B, 7.875% Series C, and 8.25% Series D Cumulative Redeemable Perpetual Preferred Stocks from Nasdaq, with a Form 25 filing expected around April 7, 2026, and last trading around April 17, 2026. This decision follows the February 12, 2026 closing of a merger where all common stock was acquired by KW Kingfisher LLC and over 80% of preferred stockholders opted for cash conversion under change of control rights. The company plans to list the preferred stock on an OTC market platform, continue SEC reporting, and maintain its REIT status without operational changes.

• ·Sotherly Hotels Inc. formed in August 2004 as an externally-managed lodging REIT focused on mid-Atlantic and southern U.S. markets.
• ·Intends to continue operating as a REIT for U.S. federal income tax purposes post-delisting.

27-03-2026

News Corporation entered into an Amended and Restated Credit Agreement dated March 27, 2026, for a US$1,500,000,000 facility, which amends and restates in its entirety the existing Credit Agreement dated March 29, 2022. The agreement establishes multicurrency revolving credit and Term A loan facilities, with Bank of America, N.A. as Administrative Agent, Citibank, N.A. and JPMorgan Chase Bank, N.A. as Co-Syndication Agents, and BOFA Securities, Inc., Citibank, N.A., and JPMorgan Chase Bank, N.A. as Joint Lead Arrangers and Joint Bookrunners.

• ·Published Deal CUSIP: 65248HAH0
• ·Published Revolving Credit Facility CUSIP: 65248HAJ6
• ·Published Term A Loan CUSIP: 65248HAK3
• ·Existing Credit Agreement dated March 29, 2022
• ·SEC Filing Items: 1.01 (Entry into Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), 9.01 (Financial Statements and Exhibits)

27-03-2026

Fermi Inc., through its subsidiaries Fermi Turbine Warehouse II LLC (Borrower), Fermi Turbine Holdco II LLC (Holdings), and Fermi Turbine Pledgor II LLC (Pledgor), entered into an Equipment Supply Loan Financing Agreement dated March 26, 2026, with lenders led by CLMG Corp. as Administrative Agent, providing a senior secured term loan facility of up to $165,000,000 to finance Equipment Acquisition Costs (including progress payments under the Equipment Supply Agreement with Siemens Energy, Inc.) and Financing Costs. As of the Closing Date, the Sponsor (Fermi Inc.) has made progress payments totaling $38,430,000. The facility includes up to $22,900,000 for interest and fees, and up to $139,080,000 for permitted Equipment Acquisition Costs, with borrowings in minimum increments of $1,000,000 and limited to 45 total during the Loan Availability Period.

• ·Original Equipment Supply Contract dated October 24, 2025, assigned to Borrower on March 26, 2026.
• ·Notice of Borrowing required 3 Banking Days (if ≤$10M) or 5 Banking Days (if >$10M) in advance.
• ·Equipment to be incorporated into one or more Project(s).

27-03-2026

Puget Energy, Inc. entered into a purchase agreement dated March 24, 2026, to issue and sell $450,000,000 aggregate principal amount of 7.000% Fixed-to-Fixed Reset Rate Junior Subordinated Notes due 2056, Series A, and $450,000,000 aggregate principal amount of 7.250% Fixed-to-Fixed Reset Rate Junior Subordinated Notes due 2056, Series B, to initial purchasers represented by Barclays Capital Inc., J.P. Morgan Securities LLC, Mizuho Securities USA LLC, and Wells Fargo Securities, LLC. The securities are issued under an indenture dated March 27, 2026, with Computershare Trust Company, National Association as trustee, in book-entry form through The Depository Trust Company. The offering relies on exemptions from Securities Act registration under Rule 144A and Regulation S, with a registration rights agreement providing for potential exchange offers.

• ·Time of Sale: 2:50 p.m. (Eastern time) on March 24, 2026
• ·Preliminary Offering Memorandum dated March 24, 2026
• ·Final Pricing Term Sheet dated March 24, 2026
• ·Securities issued only in book-entry form in the name of Cede & Co.

27-03-2026

Enterprise Products Operating LLC, a subsidiary of Enterprise Products Partners L.P., entered into a $1,500,000,000 364-Day Revolving Credit Agreement on March 27, 2026, with Citibank, N.A. as Administrative Agent and a syndicate of lenders including Wells Fargo Bank, JPMorgan Chase Bank, Mizuho Bank, MUFG Bank, Truist Bank, Barclays Bank PLC, Royal Bank of Canada, Sumitomo Mitsui Banking Corporation, The Bank of Nova Scotia, and The Toronto-Dominion Bank as key agents. The facility provides short-term revolving credit commitments, with interest rates tied to ratings-based spreads (SOFR Spread 0.710%-1.125%, ABR Spread 0%-0.125%, Facility Fee 0.040%-0.125%). No prior period comparisons or performance metrics are disclosed.

• ·Facility matures 364 days from Effective Date.
• ·Applicable Rate categories based on Index Debt ratings from Moody’s/S&P (Category 1: A1/A+ SOFR Spread 0.710%, Facility Fee 0.040%; Category 5: <Baa2/BBB SOFR Spread 1.125%, Facility Fee 0.125%).
• ·Availability Period: from Effective Date to earlier of Maturity Date or Commitments termination.

27-03-2026

LM Funding America, Inc. entered into an At The Market Offering Agreement with Maxim Group LLC on March 27, 2026, enabling the company to offer and sell shares of its common stock with an aggregate offering price of up to $75,000,000 through the agent as sales agent. The agreement provides for a 3.0% cash transaction fee on gross sales prices and reimbursement of the agent's reasonable costs up to $50,000 without further approval. No shares have been sold yet, and either party may suspend or terminate the agreement under specified conditions.

• ·Registration Statement filed with SEC on August 13, 2024, and declared effective on November 21, 2024
• ·Prospectus supplement filed with SEC on March 27, 2026
• ·ATM Agreement attached as Exhibit 1.1; Legal opinion of Foley & Lardner LLP as Exhibit 5.1
• ·Company may terminate solicitation provisions upon 10 business days' prior written notice

27-03-2026

Gen Digital Inc. entered into the Third Amendment to its Amended and Restated Credit Agreement on March 27, 2026, extending the maturity of its $1,500 million Revolving Credit Facility to March 27, 2031 (subject to a springing maturity based on a minimum liquidity test) and establishing $2,741 million in Extended Term A Loans to repay all remaining Initial Tranche A Term Loans. The Extended Term A Loans bear interest at either the base rate or SOFR plus margins based on the company's Debt Rating or Total Leverage Ratio, with annual amortization of 5.00% of the original principal and no amortization on the Revolving Facility. This refinancing extends debt maturities and provides additional liquidity flexibility.

• ·Existing Credit Agreement originally dated September 12, 2022, with prior amendments on June 5, 2024 and April 16, 2025.
• ·Extended maturities subject to springing maturity if minimum liquidity test not satisfied.
• ·Interest margins based on Debt Rating or Total Leverage Ratio (consolidated funded debt to consolidated EBITDA).

27-03-2026

Diameter Capital PC CLO 1 LLC entered into a Purchase Agreement dated March 24, 2026, with Morgan Stanley & Co. LLC as Initial Purchaser for $272,000,000 in Purchased Notes consisting of $232,000,000 Class A-1 Senior Floating Rate Notes, $16,000,000 Class A-2 Senior Floating Rate Notes, and $24,000,000 Class B Senior Floating Rate Notes, all due 2038 and secured by Collateral Obligations. The Issuer also plans to issue $127,900,000 Subordinated Notes due 2038, though not acquired by the Initial Purchaser. The notes are offered privately without Securities Act registration, with Diameter Credit Company serving as Collateral Manager and Transferor of assets via related agreements.

• ·Notes issued pursuant to Indenture dated March 24, 2026, with Western Alliance Trust Company, N.A. as Trustee.
• ·Collateral Management Agreement and Master Loan Sale Agreement also dated Closing Date (March 24, 2026).
• ·Preliminary Offering Circular dated February 10, 2026; Final Offering Circular dated March 23, 2026.

27-03-2026

Society Pass Incorporated received a Nasdaq Staff Letter on March 26, 2026, notifying that its common stock (SOPA) bid price closed below the $1.00 minimum requirement for 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2). The company has an initial 180 calendar days until September 22, 2026, to regain compliance by maintaining $1.00 or higher for 10 consecutive business days, with no immediate effect on listing or trading. Failure to comply could lead to delisting, though a potential second 180-day period is available if other listing standards are met; the company plans to monitor and explore options like a reverse stock split.

• ·Securities registered: Common Stock, par value $0.0001 per share, trading symbol SOPA on The Nasdaq Capital Market
• ·Address: 701 S. Carson Street, Suite 200, Carson City, Nevada 89701
• ·Emerging growth company: Yes
• ·Potential second compliance period of 180 calendar days if other Nasdaq Capital Market standards met, excluding bid price

27-03-2026

Immersion Corporation received a Nasdaq Staff Determination Letter on March 24, 2026, for failing to timely file 10-Qs for quarters ended July 31, 2025, October 31, 2025, and January 31, 2026, potentially leading to delisting, though trading is not immediately suspended; the company held a hearing on March 26, 2026, with no assurance of extension granted. It recently filed its 10-K for FY ended April 30, 2025, and the July 31, 2025 10-Q, while working to complete the remaining filings. Positively, the Board declared a quarterly cash dividend of $0.075 per share, payable May 1, 2026 to shareholders of record April 20, 2026.

• ·Nasdaq hearing requested pursuant to Listing Rule 5800 Series and held on March 26, 2026.
• ·10-K for fiscal year ended April 30, 2025 filed on March 12, 2026.
• ·10-Q for fiscal quarter ended July 31, 2025 filed on March 26, 2026.
• ·Common Stock trading symbol: IMMR on Nasdaq Global Market.

27-03-2026

Nu Skin Enterprises, Inc. entered into a Second Amendment and Restatement Agreement dated March 27, 2026, amending and restating its existing Credit Agreement from April 18, 2018, to facilitate a Closing Date Refinancing involving new Term Loans and a Revolving Credit Facility. Multiple subsidiaries serve as guarantors, with Bank of America, N.A. as Administrative Agent and other banks including HSBC, KeyBank, Zions Bank, Bangkok Bank, and Citibank as lenders. No specific financial metrics or performance changes are disclosed in the filing.

27-03-2026

FiEE, Inc. (NASDAQ:FIEE) has agreed to acquire a 51% equity stake in YinLian Culture for $51,000 and provide a convertible loan of approximately $2.9 million, totaling about $3.0 million investment, to control Maltose Culture's AI-empowered music ecosystem via a VIE structure. Upon optional loan conversion, FiEE's equity interest increases to 60%, aiming to integrate AI capabilities with music content creation, distribution, and home entertainment for potential growth. The deal includes a music copyright library, top performers, distribution channels, and an experienced team led by Zhang Rong.

• ·Acquisition uses VIE structure to control Maltose Culture.
• ·Maltose Culture partners with major Chinese telecommunications operator.
• ·Plans for AI-generated music tracks, videos, live events, and integration with MCN business.
• ·FiEE founded in 1977, rebranded in 2025, transitioned to Software First Model in 2024.

27-03-2026

Origin Materials reported Q4 2025 revenue of $3.0 million, down 67% YoY from $9.2 million, and full-year 2025 revenue of $18.9 million, down 40% from $31.3 million in 2024, due to the planned wind-down of its supply chain activation program. Operating expenses surged to $194.7 million in Q4 (up over 1,100% YoY) and $259.6 million for the full year (up 204% YoY), driven by a $178.8 million non-cash impairment on furanics assets, resulting in Q4 net loss of $194.1 million and full-year net loss of $249.7 million; however, Adjusted EBITDA loss narrowed slightly to $10.8 million in Q4 (from $10.5 million) and $43.4 million for the year (from $48.4 million). Cash and equivalents stood at $53.5 million, sufficient into Q3 2026, with progress on PET caps delivery to ~30 prospects and distribution deals, though breakeven now delayed to 2028 from 2027.

• ·Convertible debt facility: $15M initial tranche drawn, option for up to $90M total, but limited use due to stock price decline.
• ·Non-binding $20M equipment financing term sheet did not progress due to lender valuation changes.
• ·CapFormer production: six lines fully procured, projected installation by end of 2026.
• ·First Origin PET caps on store shelves in California in August 2025.

27-03-2026

National Fuel Gas Company entered into an Amended and Restated Credit Agreement dated March 27, 2026, fully amending and restating its prior Credit Agreement dated February 28, 2022. PNC Bank, National Association, was appointed as the new Administrative Agent, with JPMorgan Chase Bank, N.A., resigning from that role; co-syndication agents include Bank of America, N.A., JPMorgan Chase Bank, N.A., Toronto-Dominion Bank, New York Branch, and Wells Fargo Bank, National Association. The facility features pricing grids tied to credit ratings, with no changes in commitments specified in the filing.

• ·Existing Credit Agreement dated February 28, 2022
• ·Applicable Margin pricing grid based on S&P/Moody's/Fitch ratings (e.g., BBB+/Baa1/BBB+ or higher: Facility Fee 12.5 bps, Term SOFR Margin 100.0 bps)
• ·Availability Period from Effective Date to earlier of Maturity Date or Commitment termination

27-03-2026

BiomX Inc. received a notice from NYSE American on March 25, 2026, stating non-compliance with continued listing standards under Sections 1003(a)(i), (ii), and (iii) of the Company Guide due to stockholders' equity below required thresholds of $2.0 million, $4.0 million, and $6.0 million, respectively, given reported losses from continuing operations and/or net losses in two of three, three of four, and five most recent fiscal years. The company is ineligible for exemptions, including those for market capitalization over $50 million, and must submit a compliance plan by April 24, 2026, to achieve compliance by September 25, 2027, or face delisting proceedings. The notice has no immediate impact on trading of PHGE common stock, but the FY2025 auditor's report includes a going concern qualification.

• ·Company must submit compliance plan by April 24, 2026.
• ·If plan accepted, compliance required by September 25, 2027, with quarterly monitoring.
• ·Going concern qualification in auditor’s report for Form 10-K filed February 19, 2026, for fiscal year ended December 31, 2025.
• ·Common stock, $0.0001 par value, trades on NYSE American under symbol PHGE with no immediate trading impact.

27-03-2026

i-80 Gold Corp. closed a $150 million gold prepayment facility with National Bank of Canada and Macquarie Bank Limited, including a $100 million accordion feature, completing its recapitalization plan with over $1 billion in secured capital since early 2025. This funding fully supports Phases 1 and 2 development, advancing Granite Creek (underground and open pit), Archimedes, Cove projects, and Lone Tree processing facility refurbishment, targeting 300,000-400,000 ounces annual gold production by 2031 from under 50,000 ounces currently. The company anticipates executing the accordion in H1 2027 and generating cash flow for Phase 3, though output targets are preliminary and subject to risks including plant commissioning.

• ·Obligation to deliver 39,978 ounces of gold over 30-month period beginning January 2028.
• ·Accordion feature available for 24 months from closing, subject to conditions.
• ·Recapitalization completed ahead of mid-2026 target.
• ·Technical reports: Preliminary Economic Assessments for Cove (March 31, 2025), Granite Creek (March 31, 2025), Ruby Hill (March 31, 2025).
• ·All projects are exploration stage under S-K 1300; no mineral reserves determined.
• ·Output targets based on inferred resources with no certainty of realization.

27-03-2026

CareCloud, Inc. disclosed a material cybersecurity incident on March 16, 2026, involving a temporary network disruption in its CareCloud Health division that affected 1 of 6 electronic health record environments for approximately 8 hours, which was fully restored the same day with no ongoing access by the threat actor. The incident was contained, reported to authorities and cybersecurity insurance carrier, and is not believed to have materially impacted operations to date; however, an ongoing investigation assesses potential data access or exfiltration of patient information, with possible remediation costs, legal, regulatory, and reputational risks. The company has engaged external experts for forensics and remediation but has not finalized the full scope or impact.

• ·Incident reported to cybersecurity carrier and law enforcement authorities.
• ·Engaged leading cyber response advisory team from a Big Four accounting firm for investigation and remediation.
• ·Filing determined incident material on March 24, 2026, despite no current material operational impact.

27-03-2026

On March 24, 2026, GIFTIFY, INC. received a notice from Nasdaq for failing to satisfy Listing Rule 5550(a)(2), as its common stock (GIFT) had a closing bid price below $1 for 30 consecutive business days. The company has 180 calendar days to regain compliance by achieving a $1 closing bid price for at least 10 consecutive business days, with potential for an additional 180 days if other listing criteria are met, possibly via a reverse stock split. Failure to comply could result in delisting determination by Nasdaq.

• ·Trading Symbol: GIFT (Common Stock)
• ·Principal executive offices: 1100 Woodfield Road Suite 510, Schaumburg, IL 60173
• ·Commission File Number: 001-42206
• ·IRS Employer Identification No.: 45-2482974
• ·Additional compliance: Possible second 180-day period if meeting Rule 5505 standards except bid price

27-03-2026

Pulmatrix, Inc. (PULM) announced a definitive merger agreement to acquire Eos SENOLYTIX, Inc., with the combined company operating as Eos SENOLYTIX (ticker: EOSX) focused on gerotherapeutics via the MitoXcel™ platform and lead candidate PTC-2105 for sarcopenia, supported by $19 million in concurrent private financings. Pre-merger Pulmatrix stockholders are expected to own only 6% of the combined company, while Eos stockholders own 94%, indicating significant dilution for existing Pulmatrix shareholders. The merger, unanimously approved by both boards, is expected to close in mid-2026 subject to stockholder approvals and other conditions.

• ·Merger expected to close in mid-2026, subject to stockholder approvals, Form S-4 effectiveness, and customary conditions
• ·Eos led by Dr. Kevin Slawin, who will serve as CEO of combined company
• ·GLP-1 receptor agonists associated with 25-40% lean mass loss in weight reduction

27-03-2026

Q32 Bio Inc. entered into a Controlled Equity Offering Sales Agreement with Cantor Fitzgerald & Co. on March 27, 2026, establishing an at-the-market offering program for common stock with an aggregate offering price of up to $14,200,000 pursuant to its shelf registration statement (effective April 21, 2025). The Company may sell shares at its discretion through the Sales Agent, who will receive a 3.0% commission on gross proceeds, with no obligation to sell any shares. The agreement includes customary indemnification and expense reimbursement for the Sales Agent.

• ·Shelf registration statement on Form S-3 filed April 11, 2025, declared effective April 21, 2025.
• ·Prospectus supplement filed March 27, 2026.
• ·Sales may be made directly on Nasdaq or other markets as 'at-the-market offering' under Rule 415(a)(4).
• ·Either party may suspend or terminate the offering upon notice.

27-03-2026

NeoVolta, Inc. entered into a Sales Agreement with Needham & Company, LLC on March 27, 2026, enabling at-the-market sales of common stock up to an aggregate offering price of $30,000,000 for working capital and general corporate purposes, under its effective S-3 shelf registration (part of $75,000,000 total). The board appointed Steve Bond as Executive Vice President effective March 26, 2026, with his CFO role terminating May 18, 2026. Needham receives a 3.0% commission on gross proceeds, plus expense reimbursements up to $100,000 initially and $10,000 per update.

• ·Sales Agreement dated March 27, 2026; S-3 registration (File No. 333-280400) effective June 28, 2024.
• ·Steve Bond, age 52, served as CFO since February 4, 2025 per Employment Agreement.
• ·Either party may terminate Sales Agreement with 5 days' notice; Needham may terminate immediately on certain adverse events.
• ·No sales during possession of material non-public information.

27-03-2026

American Rebel Holdings, Inc. disclosed a corrected post 1-for-100 reverse stock split common shares outstanding figure of 227,554 as of March 23, 2026, down from an initial estimate of 247,988, falling short of Nasdaq's 500,000 minimum publicly held shares requirement (Nasdaq cited 247,279 publicly held). Trading remains halted under Nasdaq Listing Rule 4120(i) pending compliance, with an Additional Staff Determination adding to delisting risks ahead of a Hearings Panel. The company remains optimistic that ongoing DTC/CEDE fractional-share and round-lot top-up processing will issue additional shares to restore compliance, based on historical issuances of over 4 million and 5.8 million shares after prior splits, though no assurances on timing or Nasdaq acceptance.

• ·Reverse stock split effective March 23, 2026; record date March 20, 2026.
• ·Nasdaq Qualification Halt in place at least until publicly held shares compliance.
• ·Company to address deficiencies at Nasdaq Hearings Panel hearing on or around March 24, 2026.
• ·Continued non-compliance with $1 minimum bid price until shares deficiency cured and 10 consecutive business days of compliance (unless extended).

27-03-2026

Vor Bio announced a $75 million private placement led by new investor TCGX, involving the sale of 5,338,078 shares of common stock at $14.05 per share, with closing expected on or about March 30, 2026. Gross proceeds, before expenses, will fund advancement of telitacicept's Phase 3 trials in generalized myasthenia gravis and primary Sjögren’s disease, business development, and general corporate purposes. No placement agent was engaged, and the securities are unregistered under the Securities Act.

• ·Private placement led by TCGX with no placement agent engaged
• ·Securities not registered under Securities Act; registration rights agreement filed for resale
• ·Filing date: March 27, 2026

27-03-2026

Millrose Properties, Inc. (NYSE: MRP) closed an amendment to its credit facility with JPMorgan Chase Bank, N.A., expanding it to a $1.835 billion unsecured facility by adding a $500 million term loan commitment to the $1.335 billion revolving credit commitment, replacing the prior secured revolving facility and releasing associated liens. This enhances liquidity and financial flexibility for general corporate purposes, including refinancing existing indebtedness. CEO Darren Richman emphasized the balance sheet strength and alignment with floating rate homesite option contracts.

• ·Facility matures on March 25, 2030.
• ·Proceeds to be used for general corporate purposes, including refinancing existing indebtedness.
• ·Liens under prior secured credit facility released.
• ·Filing date: March 27, 2026.

27-03-2026

Fidelity Private Credit Company LLC (Acquired Fund), a BDC, entered into an Agreement and Plan of Merger dated March 25, 2026, with Fidelity Private Credit Company II LLC (Acquiring Fund) and Fidelity Diversifying Solutions LLC (Adviser), structured as a tax-free reorganization under Section 368(a) of the Internal Revenue Code. The transaction involves transferring all assets of the Acquired Fund to the Acquiring Fund in exchange for Acquiring Fund Units, with the Acquiring Fund assuming liabilities, followed by the pro rata distribution of units to Acquired Fund unitholders and liquidation of the Acquired Fund. As of March 24, 2026, 85,190,976.220 Class I Common Units were outstanding in the Acquired Fund, with no voting debt or outstanding rights to issue additional units.

• ·Acquired Fund financial statements as of September 30, 2025 (9-month period) furnished to Acquiring Fund and stated to fairly present financial position in conformity with GAAP.
• ·No material unresolved SEC comments or ongoing reviews as of agreement date.
• ·No material legal proceedings pending or threatened against Acquired Fund.

27-03-2026

Maison Solutions Inc. amended its Amended and Restated Certificate of Incorporation to implement a 1-for-10 reverse stock split of its Class A common stock, effective upon filing on March 23, 2026. The reverse split reclassifies every 10 shares of Old Common Stock into 1 share of New Common Stock, with fractional shares rounded up to the next whole share and no change to par value or stated capital. The amendment was approved by the Board of Directors and adopted by stockholder written consent in accordance with Delaware law.

• ·Reverse stock split applies to all issued, outstanding, and treasury shares of Class A common stock, par value $0.0001 per share
• ·Amendment signed by John Xu on March 18, 2026
• ·Filed as Exhibit 99.1 in 8-K on March 27, 2026 under Items 3.03, 5.03, 9.01

27-03-2026

Health In Tech, Inc. (Nasdaq: HIT) announced the closing of a $7.0 million private investment in public equity (PIPE) financing, issuing 5,600,000 shares of common stock at $1.25 per share to institutional and accredited investors. Gross proceeds, before fees and expenses, will support expansion of sales distribution, technology and new product development, and general corporate purposes. The financing strengthens financial flexibility for platform enhancements amid no reported declines or challenges.

• ·Craig-Hallum Capital Group LLC acted as sole placement agent; Loeb & Loeb LLP as company counsel; Faegre Drinker Biddle & Reath LLP as placement agent counsel.
• ·Securities offered under Section 4(a)(2) of Securities Act and Regulation D; not registered, with resale registration statement to be filed.
• ·Filing date: March 27, 2026